Cash flow Suzuki Motor Corporation

Equities

7269

JP3397200001

Auto & Truck Manufacturers

Market Closed - Japan Exchange Other stock markets 02:30:00 2026-04-22 am EDT			5-day change	1st Jan Change
1,825.00 ^JPY	-2.33%		-2.80%	-21.82%

09:29pm	Tesla launches new six-seater Model Y in India in attempt to boost tepid sales	RE
Apr. 16	Renault bets on EVs, hybrids to win over aspirational Indian buyers	RE

e81bae8fd82e.K5H6r4L19xWZfXb4csOMNBWDo6drDFi8bMOu2VvcpwA.GfOfmbq2nFLfSwKvFvrPW0-yx_AYa2_yOayeiw2a4zBiwJXH772BbehKJw

Published financial data: SUZUKI MOTOR CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	3,178B	3,568B	4,642B	5,374B	5,825B
Total Revenues	3,178B	3,568B	4,642B	5,374B	5,825B
Cost of Goods Sold, Total	2,312B	2,712B	3,492B	3,960B	4,257B
Gross Profit	867B	856B	1,150B	1,414B	1,569B
Selling General & Admin Expenses, Total	493B	482B	579B	701B	703B
Provision for Bad Debts	804M	2.3B	454M	-581M	-
R&D Expenses	146B	161B	206B	234B	241B
Depreciation & Amortization - (IS)	-	-	-	-	-
Other Operating Expenses	31.9B	19.58B	14.17B	14B	-15.14B
Other Operating Expenses, Total	672B	665B	799B	949B	929B
Operating Income	194B	191B	351B	466B	639B
Interest Expense, Total	-4.94B	-5.95B	-6.74B	-10.06B	-13.32B
Interest And Investment Income	41.5B	71.16B	42.61B	31.97B	34.95B
Net Interest Expenses	36.57B	65.2B	35.87B	21.91B	21.63B
Income (Loss) On Equity Invest.	7.9B	9.24B	11.61B	12.23B	12B
Currency Exchange Gains (Loss)	7.2B	1.69B	-16.92B	-9.13B	-17.69B
Other Non Operating Income (Expenses)	2.16B	-4.68B	1.7B	-2.05B	7.47B
EBT, Excl. Unusual Items	248B	263B	383B	489B	663B
Gain (Loss) On Sale Of Investments	14.17B	608M	40M	1.44B	67.58B
Gain (Loss) On Sale Of Assets	-497M	18.44B	743M	549M	111M
Asset Writedown	-5.32B	-7.69B	-2.55B	-1.24B	-335M
Other Unusual Items	-15.54B	-2M	1M	-	-
EBT, Incl. Unusual Items	241B	274B	381B	489B	730B
Income Tax Expense	71.64B	74.52B	107B	145B	201B
Earnings From Continuing Operations	169B	200B	274B	344B	530B
Net Income to Company	169B	200B	274B	344B	530B
Minority Interest	-23B	-39.41B	-53.17B	-76.51B	-114B
Net Income - (IS)	146B	160B	221B	268B	416B
Net Income to Common Incl Extra Items	146B	160B	221B	268B	416B
Net Income to Common Excl. Extra Items	146B	160B	221B	268B	416B
Per Share Items
Net EPS - Basic	75.41	82.55	113.8	138.4	215.66
Basic EPS - Continuing Operations	75.41	82.55	113.8	138.4	215.66
Basic Weighted Average Shares Outstanding	1.94B	1.94B	1.94B	1.93B	1.93B
Net EPS - Diluted	75.4	82.54	113.8	138.39	215.65
Diluted EPS - Continuing Operations	75.4	82.54	113.8	138.39	215.65
Diluted Weighted Average Shares Outstanding	1.94B	1.94B	1.94B	1.93B	1.93B
Normalized Basic EPS	68.07	64.31	95.77	118.29	155.83
Normalized Diluted EPS	68.06	64.3	95.77	118.28	155.82
Dividend Per Share	22.5	22.75	25	30.5	41
Payout Ratio	28.17	29.68	21.09	18.99	17.04
American Depositary Receipts Ratio (ADR)	4	4	4	4	4
Supplemental Items
EBITDA	331B	353B	528B	663B	889B
EBITA	194B	191B	351B	466B	639B
EBIT	194B	191B	351B	466B	639B
Effective Tax Rate - (Ratio)	29.72	27.17	28.02	29.65	27.46
Normalized Net Income	132B	125B	186B	229B	301B
Non-Cash Pension Expense	1.56B	477M	358M	3.11B	3.73B
Supplemental Operating Expense Items
Advertising Expense	123B	57.25B	63.18B	74.78B	79.31B
Selling and Marketing Expenses	221B	176B	234B	291B	348B
Research And Development Expense From Footnotes	146B	161B	206B	234B	266B

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	1,025B	964B	958B	953B	843B
Short Term Investments	202B	122B	45.4B	102B	-
Total Cash And Short Term Investments	1,226B	1,087B	1,004B	1,054B	843B
Accounts Receivable, Total	444B	427B	484B	559B	590B
Other Receivables	-	-	-	-	7.75B
Total Receivables	444B	427B	484B	559B	598B
Inventory	356B	369B	485B	592B	571B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	132B	168B	215B	233B	516B
Total Current Assets	2,159B	2,051B	2,189B	2,438B	2,529B
Net Property Plant And Equipment	979B	1,038B	1,135B	1,330B	1,723B
Long-term Investments	755B	918B	1,117B	1,524B	1,500B
Goodwill	-	-	-	-	-
Other Intangibles, Total	2.35B	3.4B	3.84B	7.8B	178B
Loans Receivable Long-Term	545M	1.24B	1.35B	1.36B	-
Deferred Tax Assets Long-Term	141B	143B	133B	85.44B	63.74B
Other Long-Term Assets, Total	2M	-	1M	2M	3M
Total Assets	4,036B	4,155B	4,578B	5,386B	5,994B
Liabilities
Accounts Payable, Total	409B	303B	383B	443B	422B
Accrued Expenses, Total	229B	202B	232B	263B	-
Short-term Borrowings	288B	95.25B	174B	167B	122B
Current Portion of Long-Term Debt	281B	95.58B	173B	290B	176B
Current Income Taxes Payable	32.14B	55.16B	44.24B	67.12B	52.79B
Deferred Tax Liability Current	-	-	-	-	-
Other Current Liabilities	449B	506B	481B	511B	830B
Total Current Liabilities	1,688B	1,257B	1,487B	1,741B	1,603B
Long-Term Debt	202B	483B	417B	329B	427B
Pension & Other Post Retirement Benefits	62.1B	64.47B	66.55B	59.91B	46.26B
Deferred Tax Liability Non Current	5.8B	6.6B	7.17B	4.11B	91.59B
Other Non Current Liabilities	46.06B	80.56B	91.16B	113B	138B
Total Liabilities	2,004B	1,891B	2,069B	2,247B	2,306B
Common Stock, Total	138B	138B	138B	138B	138B
Additional Paid In Capital	143B	143B	138B	69.08B	59.01B
Retained Earnings	1,520B	1,639B	1,813B	2,030B	2,620B
Treasury Stock	-21.03B	-20.88B	-19.4B	-39.3B	-39.17B
Comprehensive Income and Other	-92.87B	-21.27B	7.69B	293B	193B
Total Common Equity	1,688B	1,878B	2,078B	2,491B	2,971B
Minority Interest	344B	385B	431B	647B	717B
Total Equity	2,032B	2,264B	2,509B	3,138B	3,688B
Total Liabilities And Equity	4,036B	4,155B	4,578B	5,386B	5,994B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.94B	1.94B	1.94B	1.93B	1.93B
ECS Total Common Shares Outstanding	1.94B	1.94B	1.94B	1.93B	1.93B
Book Value / Share	868.89	966.94	1.07K	1.29K	1.54K
Tangible Book Value	1,685B	1,875B	2,074B	2,483B	2,792B
Tangible Book Value Per Share	867.68	965.19	1.07K	1.29K	1.45K
Total Debt	771B	674B	764B	786B	725B
Net Debt	-455B	-412B	-240B	-268B	-117B
Debt Equivalent of Unfunded Proj. Benefit Obligation	57.82B	56.08B	58.96B	40.65B	9.75B
Minority Interest, Total (Incl. Fin. Div)	344B	385B	431B	647B	717B
Equity Method Investments, Total	-	-	-	-	116B
Inventories - Raw Materials, Total	63.04B	88.36B	110B	103B	82.27B
Inventories - Work In Process, Total	46.3B	66.62B	61.29B	52.11B	73.58B
Inventories - Finished Goods, Total	247B	214B	314B	437B	416B
Inventories - Others	-	-	-	-	1M
Full Time Employees	68.74K	69.19K	70.01K	72.37K	74.08K
Accumulated Allowance for Doubtful Accounts (Supple)	4.14B	6.79B	7.38B	7.19B	6.96B

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	241B	274B	381B	489B	730B
Depreciation & Amortization - CF	137B	162B	177B	197B	250B
Depreciation & Amortization, Total	137B	162B	177B	197B	250B
(Gain) Loss From Sale Of Asset	5.82B	-10.75B	1.81B	688M	335M
(Gain) Loss on Sale of Investments - (CF)	-14.17B	-607M	-40M	-1.44B	-
(Income) Loss On Equity Investments - (CF)	-7.9B	-9.24B	-11.61B	-12.23B	-12B
Other Operating Activities, Total	-41.52B	-59.4B	-106B	-130B	-244B
Change In Accounts Receivable	-5.55B	66.89B	-53.62B	-47.31B	-8.84B
Change In Inventories	22.14B	9.52B	-115B	-51.53B	-16.21B
Change In Accounts Payable	79.04B	-157B	115B	25.49B	-4.59B
Change in Other Net Operating Assets	-34M	-53.76B	-103B	-24.02B	-25.46B
Cash from Operations	415B	221B	287B	446B	670B
Capital Expenditure	-172B	-190B	-258B	-306B	-345B
Sale of Property, Plant, and Equipment	-	22.48B	2.73B	6.16B	7.24B
Sale (Purchase) of Intangible assets	-	-	-	-	-57.82B
Investment in Marketable and Equity Securities, Total	-129B	93.56B	106B	-77.82B	-44.51B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-2.46B
Other Investing Activities, Total	67.23B	-79.08B	-153B	-56.51B	-33.36B
Cash from Investing	-233B	-154B	-303B	-434B	-476B
Short Term Debt Issued, Total	153B	-	87.19B	-	-
Long-Term Debt Issued, Total	285B	379B	110B	204B	294B
Total Debt Issued	438B	379B	197B	204B	294B
Short Term Debt Repaid, Total	-	-194B	-	-15.61B	-41.5B
Long-Term Debt Repaid, Total	-83.14B	-283B	-101B	-177B	-311B
Total Debt Repaid	-83.14B	-477B	-101B	-192B	-353B
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-	-	-	-20B	-1M
Common Dividends Paid	-41.25B	-47.59B	-46.63B	-50.83B	-70.9B
Common & Preferred Stock Dividends Paid	-41.25B	-47.59B	-46.63B	-50.83B	-70.9B
Other Financing Activities, Total	-11.45B	-9.05B	-18.44B	-22.08B	-57.06B
Cash from Financing	303B	-155B	31.57B	-81.22B	-186B
Foreign Exchange Rate Adjustments	18.91B	20.48B	8.63B	40.53B	-5.51B
Miscellaneous Cash Flow Adjustments	-	1M	0	1M	-2M
Net Change in Cash	504B	-66.4B	24.15B	-28.51B	2.69B
Supplemental Items
Cash Interest Paid	5.02B	6.17B	5.82B	8.44B	10.95B
Cash Income Tax Paid (Refund)	41.77B	59.24B	106B	132B	175B
Levered Free Cash Flow	179B	1.16B	-11.5B	122B	-43.63B
Unlevered Free Cash Flow	182B	4.88B	-7.29B	128B	-35.3B
Change In Net Working Capital	-95.31B	85.82B	145B	54.66B	282B
Net Debt Issued / Repaid	355B	-97.99B	96.63B	11.69B	-58.02B

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	3.29	2.92	5.02	5.84	7.02
Return on Total Capital	4.86	4.17	7.06	8.09	9.59
Return On Equity %	8.86	9.3	11.49	12.19	15.52
Return on Common Equity	9.22	8.99	11.18	11.72	15.24
Margin Analysis
Gross Profit Margin %	27.27	24	24.77	26.32	26.93
SG&A Margin	15.52	13.52	12.48	13.05	12.07
EBITDA Margin %	10.41	9.89	11.37	12.33	15.27
EBITA Margin %	6.12	5.37	7.55	8.66	10.98
EBIT Margin %	6.12	5.37	7.55	8.66	10.98
Income From Continuing Operations Margin %	5.33	5.6	5.91	6.4	9.09
Net Income Margin %	4.61	4.49	4.76	4.98	7.14
Net Avail. For Common Margin %	4.61	4.49	4.76	4.98	7.14
Normalized Net Income Margin	4.16	3.5	4.01	4.26	5.16
Levered Free Cash Flow Margin	5.62	0.03	-0.25	2.26	-0.75
Unlevered Free Cash Flow Margin	5.72	0.14	-0.16	2.38	-0.61
Asset Turnover
Asset Turnover	0.86	0.87	1.06	1.08	1.02
Fixed Assets Turnover	3.35	3.54	4.27	4.36	3.82
Receivables Turnover (Average Receivables)	7.32	8.19	10.19	10.31	10.14
Inventory Turnover (Average Inventory)	6.5	7.48	8.17	7.35	7.32
Short Term Liquidity
Current Ratio	1.28	1.63	1.47	1.4	1.58
Quick Ratio	0.99	1.2	1	0.93	0.9
Operating Cash Flow to Current Liabilities	0.25	0.18	0.19	0.26	0.42
Days Sales Outstanding (Average Receivables)	49.9	44.58	35.82	35.5	36
Days Outstanding Inventory (Average Inventory)	56.16	48.81	44.68	49.78	49.87
Average Days Payable Outstanding	58.34	47.66	34.69	37.16	37.25
Cash Conversion Cycle (Average Days)	47.72	45.73	45.81	48.12	48.62
Long Term Solvency
Total Debt/Equity	37.94	29.78	30.45	25.05	19.67
Total Debt / Total Capital	27.5	22.95	23.34	20.03	16.43
LT Debt/Equity	9.94	21.35	16.61	10.5	11.59
Long-Term Debt / Total Capital	7.21	16.45	12.74	8.39	9.69
Total Liabilities / Total Assets	49.66	45.52	45.2	41.73	38.47
EBIT / Interest Expense	39.4	32.16	52	46.29	48
EBITDA / Interest Expense	67.07	59.28	78.3	65.9	66.76
(EBITDA - Capex) / Interest Expense	32.27	27.29	39.99	35.51	40.88
Total Debt / EBITDA	2.33	1.91	1.45	1.19	0.82
Net Debt / EBITDA	-1.38	-1.17	-0.45	-0.4	-0.13
Total Debt / (EBITDA - Capex)	4.84	4.15	2.83	2.2	1.33
Net Debt / (EBITDA - Capex)	-2.86	-2.54	-0.89	-0.75	-0.22
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-8.89	12.28	30.08	15.78	8.39
Gross Profit, 1 Yr. Growth %	-10.99	-1.18	34.27	23	10.9
EBITDA, 1 Yr. Growth %	-12.72	6.64	49.54	25.57	34.18
EBITA, 1 Yr. Growth %	-9.6	-1.53	83.09	32.81	37.35
EBIT, 1 Yr. Growth %	-9.6	-1.53	83.09	32.81	37.35
Earnings From Cont. Operations, 1 Yr. Growth %	4.19	17.91	37.31	25.5	53.89
Net Income, 1 Yr. Growth %	9.09	9.51	37.89	21.08	55.41
Normalized Net Income, 1 Yr. Growth %	4.78	-5.48	48.97	22.97	31.38
Diluted EPS Before Extra, 1 Yr. Growth %	5.34	9.47	37.86	21.61	55.83
Accounts Receivable, 1 Yr. Growth %	4.71	-3.88	13.27	15.47	5.64
Inventory, 1 Yr. Growth %	0.12	3.8	31.36	21.93	-3.43
Net Property, Plant and Equip., 1 Yr. Growth %	6.39	6.03	9.3	17.22	29.6
Total Assets, 1 Yr. Growth %	20.86	2.94	10.17	17.65	11.29
Tangible Book Value, 1 Yr. Growth %	13.4	11.25	10.63	19.72	12.45
Common Equity, 1 Yr. Growth %	13.44	11.3	10.64	19.87	19.25
Cash From Operations, 1 Yr. Growth %	142.19	-46.74	29.54	55.62	50.16
Capital Expenditures, 1 Yr. Growth %	-30.15	10.93	35.6	18.36	12.76
Levered Free Cash Flow, 1 Yr. Growth %	-251.9	-99.35	-1.09K	-1.16K	-135.89
Unlevered Free Cash Flow, 1 Yr. Growth %	-259.22	-97.31	-249.27	-1.85K	-127.61
Dividend Per Share, 1 Yr. Growth %	21.62	1.11	9.89	22	34.43
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-9.4	1.14	20.85	22.72	12.03
Gross Profit, 2 Yr. CAGR %	-12.52	-6.21	15.19	28.51	16.8
EBITDA, 2 Yr. CAGR %	-16.35	-3.52	26.28	37.03	29.8
EBITA, 2 Yr. CAGR %	-22.54	-5.65	34.27	55.94	35.06
EBIT, 2 Yr. CAGR %	-22.54	-5.65	34.27	55.94	35.06
Earnings From Cont. Operations, 2 Yr. CAGR %	-15.43	10.84	27.24	31.27	38.97
Net Income, 2 Yr. CAGR %	-9.5	9.3	22.89	29.21	37.17
Normalized Net Income, 2 Yr. CAGR %	-14.13	-0.48	18.66	35.35	27.1
Diluted EPS Before Extra, 2 Yr. CAGR %	-12.64	7.39	22.85	29.48	37.66
Accounts Receivable, 2 Yr. CAGR %	0.44	0.32	4.34	14.36	10.45
Inventory, 2 Yr. CAGR %	0.57	1.94	16.77	26.56	8.51
Net Property, Plant and Equip., 2 Yr. CAGR %	4.05	6.21	7.65	13.19	23.25
Total Assets, 2 Yr. CAGR %	8.93	11.54	6.5	13.85	14.43
Tangible Book Value, 2 Yr. CAGR %	10.1	12.32	10.94	15.09	16.03
Common Equity, 2 Yr. CAGR %	10.08	12.36	10.97	15.16	19.56
Cash From Operations, 2 Yr. CAGR %	4.09	13.57	-16.94	41.98	52.87
Capital Expenditures, 2 Yr. CAGR %	-17.37	-11.98	22.65	26.68	15.52
Levered Free Cash Flow, 2 Yr. CAGR %	-22.61	-90.07	-74.62	923.72	94.78
Unlevered Free Cash Flow, 2 Yr. CAGR %	-22.29	-79.32	-79.97	411.77	120.12
Dividend Per Share, 2 Yr. CAGR %	10.28	10.89	5.41	15.79	28.06
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-5.43	-2.68	9.99	19.14	17.75
Gross Profit, 3 Yr. CAGR %	-7.8	-8.89	5.7	17.74	22.35
EBITDA, 3 Yr. CAGR %	-14.23	-9.3	11.65	26.04	36.07
EBITA, 3 Yr. CAGR %	-19.57	-16.09	17.69	33.78	49.48
EBIT, 3 Yr. CAGR %	-19.57	-16.09	17.69	33.78	49.48
Earnings From Cont. Operations, 3 Yr. CAGR %	-14.96	-5.52	19.04	26.66	38.41
Net Income, 3 Yr. CAGR %	-12.12	-3.56	18.1	22.28	37.41
Normalized Net Income, 3 Yr. CAGR %	-9.74	-11.34	13.84	20.08	34.01
Diluted EPS Before Extra, 3 Yr. CAGR %	-13.97	-5.82	16.71	22.44	37.73
Accounts Receivable, 3 Yr. CAGR %	5.02	-1.02	4.46	7.93	11.38
Inventory, 3 Yr. CAGR %	0.28	1.64	10.93	18.47	15.65
Net Property, Plant and Equip., 3 Yr. CAGR %	6.77	4.7	7.23	10.75	18.41
Total Assets, 3 Yr. CAGR %	6.51	6.89	11.08	10.09	12.99
Tangible Book Value, 3 Yr. CAGR %	9.17	10.48	11.76	13.79	14.2
Common Equity, 3 Yr. CAGR %	9.15	10.49	11.79	13.86	16.51
Cash From Operations, 3 Yr. CAGR %	-2.28	-16.75	18.66	2.4	44.66
Capital Expenditures, 3 Yr. CAGR %	-5.87	-8.85	1.66	21.2	21.86
Levered Free Cash Flow, 3 Yr. CAGR %	-0.77	-84.27	-53.93	-12.03	235.06
Unlevered Free Cash Flow, 3 Yr. CAGR %	-1.12	-74.69	-60.03	-11.05	93.39
Dividend Per Share, 3 Yr. CAGR %	6.74	7.14	10.56	10.67	21.69
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-0.02	2.4	4.32	6.78	10.8
Gross Profit, 5 Yr. CAGR %	-0.01	-1.15	0.79	4.55	10.01
EBITDA, 5 Yr. CAGR %	-1.85	-3.85	0.12	6.98	18.59
EBITA, 5 Yr. CAGR %	-0.06	-6.38	-1.27	7.52	24.35
EBIT, 5 Yr. CAGR %	-0.06	-6.38	-1.27	7.52	24.35
Earnings From Cont. Operations, 5 Yr. CAGR %	2.02	0.22	-0.08	7.76	26.64
Net Income, 5 Yr. CAGR %	4.65	0.05	0.49	8.41	25.39
Normalized Net Income, 5 Yr. CAGR %	6.85	-2.47	0.69	5.01	18.97
Diluted EPS Before Extra, 5 Yr. CAGR %	5.12	-1.85	-0.8	6.97	24.68
Accounts Receivable, 5 Yr. CAGR %	6.19	4.44	4.75	4.87	6.82
Inventory, 5 Yr. CAGR %	4.45	2.15	6.58	10.95	9.96
Net Property, Plant and Equip., 5 Yr. CAGR %	5.27	6.54	7.12	8.02	13.37
Total Assets, 5 Yr. CAGR %	8.36	5.92	6.5	9.62	12.41
Tangible Book Value, 5 Yr. CAGR %	12.06	10.91	9.88	12.3	13.45
Common Equity, 5 Yr. CAGR %	11.99	10.89	9.88	12.33	14.83
Cash From Operations, 5 Yr. CAGR %	7.15	-9.59	-8.43	3.07	31.32
Capital Expenditures, 5 Yr. CAGR %	1.1	-0.17	4.64	3.98	6.99
Levered Free Cash Flow, 5 Yr. CAGR %	4.67	-62.64	-42.49	-16.43	-17.98
Unlevered Free Cash Flow, 5 Yr. CAGR %	4.45	-50.39	-47.79	-15.73	-20.91
Dividend Per Share, 5 Yr. CAGR %	22.98	15.64	6.21	10.52	17.25